The University of Chicago Header Logo

Connection

Louis Philipson to Metformin

Back to Details
This is a "connection" page, showing publications Louis Philipson has written about Metformin.
Louis Philipson
Connection Strength
0.186
Metformin
  1. First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists : A Cost-Effectiveness Study. Ann Intern Med. 2022 10; 175(10):1392-1400.
    View in: PubMed
    Score: 0.186
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.